Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Careers | Investor Relations | News & Media | Events | KCI Recycling | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education and Training  |  For Patients  |  Customer Support  |  Suppliers

Welcome to KCI, Leader in Advanced Wound Care Solutions

Features

News   Medical Professionals   Patient Stories
KCI, Leader in Advanced Wound Care Solutions Acelity Appoints Gaurav S. Agarwal as Group President, Businesses and Innovation
V.A.C. Ulta Negative Therapy System V.A.C.Ulta™ Negative Pressure Wound Therapy System
V.A.C.Ulta™ Negative Pressure Wound Therapy System with V.A.C. VeraFlo™ Therapy is the first and only NPT System with instillation therapy featuring both soak time and automated volumetric delivery of topical wound treatment solutions to the wound bed.
Photo of Bill Brown Bill's Story

Learn how V.A.C®. Therapy helped Bill Brown return home to his family.

KCI, Leader in Advanced Wound Care Solutions Thomas Casey Named Executive Vice President, Chief Financial Officer for Acelity
ABThera ABThera™ OA Negative Pressure Therapy Unit
A temporary abdominal closure therapy system that enables healthcare professionals to take control early when managing a challenging open abdomen, helping to achieve primary fascial closure.

KCI Express

Submit and track rental and disposable orders using KCI’s secure Web interface.


Important Message for Patients

Terms of Use | Privacy Policy | Contact Us | News Feed


Copyright © 1998 - 2013 KCI Licensing, Inc. All Rights Reserved.    DSL# 09-03-193
The information included in this Web site has been prepared for and is intended for viewing exclusively within the United States of America. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.